Primary indicators
allergic symptoms
Primary outcomes were assessed before treatment (baseline), at 3 month, 6 month, 12 month, 24 month and 36 month, including (1) change in allergic symptoms associated with dust mite was assessed by a four-scale system where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, and 3=most severe symptoms (